PROVIDENCE, R.I. [Brown University] — The National Institute on Aging has awarded a $4.2 million grant to a research team based at Brown University and Hebrew SeniorLife to partner with CVS Health to develop a massive, data-driven monitoring system that tracks the long-term safety and efficacy of COVID-19 vaccination for Medicare beneficiaries.
The members of this group, who are age 65 and older and tend to have more diagnoses of Alzheimer’s disease, dementia and other disorders, are at greatest risk for severe illness from the coronavirus, the researchers say.
“The goal is to leverage ‘big data’ to save lives,” said project leader Vincent Mor, a professor of health services, policy and practice at Brown’s School of Public Health. “With this project, we’re uniquely positioned to securely monitor more than 13 million CVS customers who are Medicare beneficiaries. We’ll be able to determine the prevalence of known adverse reactions to the vaccine and whether the vaccine protects them from coming down with COVID in the future.” READ MORE